目次

Table of Contents

1. Executive Summary

2. Introduction

2.1 Oncology NGS: An Overview
2.1.1 Definition of Oncology NGS
2.1.2 Benefits of Oncology NGS

2.2 Oncology NGS Segmentation: An Overview
2.2.1 Oncology NGS Segmentation

3. Global Market Analysis

3.1 Global Oncology NGS Market: An Analysis

3.1.1 Global Oncology NGS Market: An Overview
3.1.2 Global Oncology NGS Market by Value
3.1.3 Global Oncology NGS Market by Technology
3.1.4 Global Oncology NGS Market by Work Flow
3.1.5 Global Oncology NGS Market by Application
3.1.6 Global Oncology NGS Market by End User
3.1.7 Global Oncology NGS Market by Region

3.2 Global Oncology NGS Market: Technology Analysis

3.2.1 Global Oncology NGS Market by Technology: An Overview
3.2.2 Global Targeted Sequencing & Resequencing Oncology NGS Market by Value
3.2.3 Global Whole Exome Sequencing Oncology NGS Market by Value
3.2.4 Global Whole Genome Sequencing Oncology NGS Market by Value

3.3 Global Oncology NGS Market: Work Flow Analysis

3.3.1 Global Oncology NGS Market by Work Flow: An Overview
3.3.2 Global Oncology NGS Sequencing Market by Value
3.3.3 Global Oncology NGS Pre-sequencing Market by Value
3.3.4 Global Oncology NGS Data Analysis Market by Value

3.4 Global Oncology NGS Market: Application Analysis

3.4.1 Global Oncology NGS Market by Application: An Overview
3.4.2 Global Screening Oncology NGS Market by Value
3.4.3 Global Companion Diagnostics Oncology NGS Market by Value
3.4.4 Global Other Diagnostics Oncology NGS Market by Value

3.5 Global Oncology NGS Market: End User Analysis

3.5.1 Global Oncology NGS Market by End User: An Overview
3.5.2 Global Laboratories Oncology NGS Market by Value
3.5.3 Global Hospitals Oncology NGS Market by Value
3.5.4 Global Clinics Oncology NGS Market by Value

4. Regional Market Analysis

4.1 North America Oncology NGS Market: An Analysis

4.1.1 North America Oncology NGS Market: An Overview
4.1.2 North America Oncology NGS Market by Value
4.1.3 North America Oncology NGS Market by Region
4.1.4 The US Oncology NGS Market by Value
4.1.5 Canada Oncology NGS Market by Value
4.1.6 Mexico Oncology NGS Market by Value

4.2 Europe Oncology NGS Market: An Analysis

4.2.1 Europe Oncology NGS Market: An Overview
4.2.2 Europe Oncology NGS Market by Value
4.2.3 Europe Oncology NGS Market by Region
4.2.4 Germany Oncology NGS Market by Value
4.2.5 United Kingdom Oncology NGS Market by Value
4.2.6 France Oncology NGS Market by Value
4.2.7 Spain Oncology NGS Market by Value
4.2.8 Italy Oncology NGS Market by Value
4.2.9 Rest of Europe Oncology NGS Market by Value

4.3 Asia Pacific Oncology NGS Market: An Analysis

4.3.1 Asia Pacific Oncology NGS Market: An Overview
4.3.2 Asia Pacific Oncology NGS Market by Value
4.3.3 Asia Pacific Oncology NGS Market by Region
4.3.4 China Oncology NGS Market by Value
4.3.5 Japan Oncology NGS Market by Value
4.3.6 India Oncology NGS Market by Value
4.3.7 South Korea Oncology NGS Market by Value
4.3.8 Rest of Asia Pacific Oncology NGS Market by Value

4.4 Rest of the World Oncology NGS Market: An Analysis

4.4.1 Rest of the World Oncology NGS Market: An Overview
4.4.2 Rest of the World Oncology NGS Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Oncology NGS Market
5.2 Post COVID-19 Impact on Global Oncology NGS Market

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Rising Cancer Incidence
6.1.2 Growing Healthcare Expenditure
6.1.3 Government Initiatives
6.1.4 Cost Reduction

6.2 Challenges
6.2.1 Complex Data Analysis and Interpretation
6.2.2 Ethical and Privacy Concerns

6.3 Market Trends
6.3.1 Integration with AI and Bioinformatics
6.3.2 Liquid Biopsies Innovations
6.3.3 Increased Focus on Personalized Medicine
6.3.4 Rise of Companion Diagnostics
6.3.5 Advancements in Sequencing Technologies
6.3.6 Increased R&D Investments
6.3.7 Decentralization of NGS Testing

7. Competitive Landscape

7.1 Global Newborn Screening Market: Competitive Landscape
7.2 Global Newborn Screening Market: Recent Developments

8. Company Profiles

8.1 Thermo Fisher Scientific Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Agilent Technologies, Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Qiagen
8.3.1 Business Overview
8.3.2 Sales by Product Group
8.3.3 Business Strategy

8.4 Illumina, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Roche Holdings AG
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 Revvity, Inc.
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy

8.7 Pacific Biosciences of California, Inc.
8.7.1 Business Overview
8.7.2 Revenue by Geography
8.7.3 Business Strategy

8.8 Myriad Genetics, Inc.
8.8.1 Business Overview
8.8.2 Business Strategy

8.9 Oxford Nanopore Technologies
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 BGI Group (Beijing Genomics)
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Caris Life Sciences
8.11.1 Business Overview
8.11.2 Business Strategy

List of Figures
Figure 1: Benefits of Oncology NGS
Figure 2: Oncology NGS Segmentation
Figure 3: Global Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 4: Global Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 5: Global Oncology NGS Market by Technology; 2023 (Percentage, %)
Figure 6: Global Oncology NGS Market by Work Flow; 2023 (Percentage, %)
Figure 7: Global Oncology NGS Market by Application; 2023 (Percentage, %)
Figure 8: Global Oncology NGS Market by End User; 2023 (Percentage, %)
Figure 9: Global Oncology NGS Market by Region; 2023 (Percentage, %)
Figure 10: Global Targeted Sequencing & Resequencing Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 11: Global Targeted Sequencing & Resequencing Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 12: Global Whole Exome Sequencing Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 13: Global Whole Exome Sequencing Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 14: Global Whole Genome Sequencing Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 15: Global Whole Genome Sequencing Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 16: Global Oncology NGS Sequencing Market by Value; 2019-2023 (US$ Million)
Figure 17: Global Oncology NGS Sequencing Market by Value; 2024-2029 (US$ Million)
Figure 18: Global Oncology NGS Pre-sequencing Market by Value; 2019-2023 (US$ Million)
Figure 19: Global Oncology NGS Pre-sequencing Market by Value; 2024-2029 (US$ Million)
Figure 20: Global Oncology NGS Data Analysis Market by Value; 2019-2023 (US$ Million)
Figure 21: Global Oncology NGS Data Analysis Market by Value; 2024-2029 (US$ Million)
Figure 22: Global Screening Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Screening Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 24: Global Companion Diagnostics Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 25: Global Companion Diagnostics Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 26: Global Other Diagnostics Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 27: Global Other Diagnostics Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 28: Global Laboratories Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 29: Global Laboratories Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 30: Global Hospitals Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 31: Global Hospitals Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 32: Global Clinics Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 33: Global Clinics Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 34: North America Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 35: North America Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 36: North America Oncology NGS Market by Region; 2023 (Percentage, %)
Figure 37: The US Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 38: The US Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 39: Canada Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 40: Canada Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 41: Mexico Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 42: Mexico Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 43: Europe Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 44: Europe Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 45: Europe Oncology NGS Market by Region; 2023 (Percentage, %)
Figure 46: Germany Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 47: Germany Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 48: United Kingdom Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 49: United Kingdom Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 50: France Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 51: France Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 52: Spain Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 53: Spain Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 54: Italy Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 55: Italy Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 56: Rest of Europe Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 57: Rest of Europe Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 58: Asia Pacific Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 59: Asia Pacific Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 60: Asia Pacific Oncology NGS Market by Region; 2023 (Percentage, %)
Figure 61: China Oncology NGS Market by Value, 2019-2023 (US$ Million)
Figure 62: China Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 63: Japan Oncology NGS Market by Value, 2019-2023 (US$ Million)
Figure 64: Japan Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 65: India Oncology NGS Market by Value, 2019-2023 (US$ Million)
Figure 66: India Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 67: South Korea Oncology NGS Market by Value, 2019-2023 (US$ Million)
Figure 68: South Korea Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 69: Rest of Asia Pacific Oncology NGS Market by Value, 2019-2023 (US$ Million)
Figure 70: Rest of Asia Pacific Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 71: Rest of the World Oncology NGS Market by Value; 2019-2023 (US$ Million)
Figure 72: Rest of the World Oncology NGS Market by Value; 2024-2029 (US$ Million)
Figure 73: Global Estimated Number of New Cases; 2022 to 2050, Males and Females (Million)
Figure 74: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 75: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 76: Thermo Fisher Scientific Inc. Revenues by Segments; 2023 (Percentage, %)
Figure 77: Agilent Technologies, Inc. Revenue by Segments; 2023 (Percentage, %)
Figure 78: Qiagen Net Sales by Product Group; 2023 (Percentage, %)
Figure 79: Illumina Revenue by Segments; 2023 (Percentage, %)
Figure 80: Roche Holdings AG Sales by Operating Segment; 2023 (Percentage, %)
Figure 81: Revvity, Inc. Revenue by Segments; 2023 (Percentage, %)
Figure 82: Pacific Biosciences of California, Inc. Revenue by Geography; 2023 (Percentage, %)